Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 24, Pages 20430-20442Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.275610
Keywords
-
Categories
Funding
- Kidney Foundation of Japan [JKFB09-41]
- Mitsui Sumitomo Welfare Foundation
- Japan Science and Technology Agency
- [19590973]
- [21591033]
- Grants-in-Aid for Scientific Research [24659279, 24591201, 21591033, 23659445, 22390169] Funding Source: KAKEN
Ask authors/readers for more resources
Activation of mesangial cells (MCs), which is characterized by induction of smooth muscle alpha-actin (SMA) expression, contributes to a key event in various renal diseases; however, the mechanisms controlling MC differentiation are still largely undefined. Activated Smad1 induced SMA in a dose-dependent manner in MCs. As a direct regulating molecule for SMA, we identified and characterized scleraxis (Scx) as a new phenotype modulator in advanced glycation end product (AGE)-exposed MCs. Scx physically associated with E12 and bound the E-box in the promoter of SMA and negatively regulated the AGE-induced SMA expression. Scx induced expression and secretion of bone morphogenetic protein 4 (BMP4), thereby controlling the Smad1 activation in AGE-treated MCs. In diabetic mice, Scx was concomitantly expressed with SMA in the glomeruli. Inhibitor of differentiation 1 (Id1) was further induced by extended treatment with AGE, thereby dislodging Scx from the SMA promoter. These data suggest that Scx and Id1 are involved in the BMP4-Smad1-SMA signal transduction pathway besides the TGF beta 1-Smad1-SMA signaling pathway and modulate phenotypic changes in MCs in diabetic nephropathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available